September 26, 2013
…organization committed to stopping Alzheimer’s by 2020. Proceeds from the performance benefit the UC San Diego Shiley-Marcos Alzheimer’s Disease Research Center and WomenAgainst Alzheimer’s – the first national network of women in leadership positions working to speed the pace of research and build momentum to end Alzheimer’s disease. “Through my…
July 3, 2019
On July 1, 2019, USC and UC San Diego reached a settlement in the ongoing Alzheimer’s disease research lawsuit, Regents of the University of California v. Aisen et al.
January 13, 2016
…of California, San Diego School of Medicine and the Alzheimer’s Disease Cooperative Study (ADCS), in collaboration with AC Immune, a biotechnology company based in Switzerland, will test the safety and tolerability of an immunotherapy vaccine that targets Alzheimer’s disease-like characteristics in adults with Down syndrome.
May 15, 2012
Researchers at the Comprehensive Alzheimer’s Program at the University of California, San Diego School of Medicine have announced two new clinical trials for patients with either mild to moderate Alzheimer’s disease (AD) and one trial for Mild Cognitive Impairment.
August 21, 2023
New results from researchers at UC San Diego School of Medicine suggest that intermittent fasting could be an effective treatment approach for Alzheimer’s disease. Mice fed on a time-restricted schedule had better memory and less accumulation of amyloid proteins in the brain compared to controls.
August 20, 2024
Researchers from UC San Diego are working on a new treatment for Alzheimer’s that targets tau - a type of protein in the brain that helps cells retain their stability and structure.
November 13, 2020
UC San Diego researchers have identified new mechanisms in neurons that cause Alzheimer’s disease. In particular, they discovered that structural changes in chromatin trigger neurons to lose their specialized function and revert to a precursor-like state.
February 19, 2013
…between neurons, and describe how a compound linked to Alzheimer’s disease impacts that receptor and weakens synaptic connections between brain cells.
March 31, 2020
UC San Diego researchers discovered that high blood levels of RNA produced by the PHGDH gene could serve as a biomarker for early detection of Alzheimer’s. The work could lead to the development of a blood test to identify individuals who will develop the disease years before they show symptoms.
September 17, 2015
…Americans are living with Alzheimer’s disease (AD). Of them, 400,000 also have Down syndrome. Both groups have similar looking brains with higher levels of the protein beta amyloid. In fact, patients with Down syndrome develop the abnormal protein at twice the rate. Results of a pilot study confirms the pathogenic…
